Given the limited sensitivity of proteomics by mass spectrometry, and that OMD was reported to be positively associated with BMP4/6 in atherosclerotic plaques,[46] further investigations were needed to clarify the potential interaction of OMD and other BMPs. The gene discussed is CLN5; the disease is occult macular dystrophy.